vs

Side-by-side financial comparison of Community West Bancshares (CWBC) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $34.2M, roughly 1.1× PRECISION BIOSCIENCES INC). On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 11.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-11.3M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 36.0%).

Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

CWBC vs DTIL — Head-to-Head

Bigger by revenue
CWBC
CWBC
1.1× larger
CWBC
$38.3M
$34.2M
DTIL
Growing faster (revenue YoY)
DTIL
DTIL
+5249.6% gap
DTIL
5261.1%
11.6%
CWBC
More free cash flow
CWBC
CWBC
$54.9M more FCF
CWBC
$43.6M
$-11.3M
DTIL
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
36.0%
CWBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWBC
CWBC
DTIL
DTIL
Revenue
$38.3M
$34.2M
Net Profit
$20.1M
Gross Margin
Operating Margin
40.0%
36.6%
Net Margin
58.9%
Revenue YoY
11.6%
5261.1%
Net Profit YoY
213.5%
EPS (diluted)
$0.58
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWBC
CWBC
DTIL
DTIL
Q4 25
$38.3M
$34.2M
Q3 25
$37.9M
$13.0K
Q2 25
$35.7M
$18.0K
Q1 25
$34.8M
$29.0K
Q4 24
$34.3M
$638.0K
Q3 24
$31.3M
$576.0K
Q2 24
$30.5M
$49.9M
Q1 24
$20.7M
$17.6M
Net Profit
CWBC
CWBC
DTIL
DTIL
Q4 25
$20.1M
Q3 25
$10.9M
$-21.8M
Q2 25
$7.8M
$-23.5M
Q1 25
$8.3M
$-20.6M
Q4 24
Q3 24
$3.4M
$-16.4M
Q2 24
$-6.3M
$32.7M
Q1 24
$3.7M
$8.6M
Operating Margin
CWBC
CWBC
DTIL
DTIL
Q4 25
40.0%
36.6%
Q3 25
39.8%
-158976.9%
Q2 25
30.2%
-121538.9%
Q1 25
32.7%
-76248.3%
Q4 24
31.0%
Q3 24
13.3%
-3693.6%
Q2 24
-25.9%
48.4%
Q1 24
23.2%
-23.8%
Net Margin
CWBC
CWBC
DTIL
DTIL
Q4 25
58.9%
Q3 25
28.7%
-167476.9%
Q2 25
22.0%
-130666.7%
Q1 25
23.8%
-70913.8%
Q4 24
Q3 24
10.8%
-2851.6%
Q2 24
-20.7%
65.6%
Q1 24
17.8%
48.8%
EPS (diluted)
CWBC
CWBC
DTIL
DTIL
Q4 25
$0.58
$2.62
Q3 25
$0.57
$-1.84
Q2 25
$0.41
$-2.13
Q1 25
$0.44
$-2.21
Q4 24
$0.29
Q3 24
$0.18
$-2.25
Q2 24
$-0.33
$4.67
Q1 24
$0.31
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWBC
CWBC
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$119.0M
$115.6M
Total DebtLower is stronger
$69.5M
Stockholders' EquityBook value
$409.6M
$92.2M
Total Assets
$3.7B
$154.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWBC
CWBC
DTIL
DTIL
Q4 25
$119.0M
$115.6M
Q3 25
$121.6M
$44.9M
Q2 25
$134.4M
$62.2M
Q1 25
$148.4M
$77.2M
Q4 24
$120.4M
$86.3M
Q3 24
$149.0M
$101.2M
Q2 24
$109.7M
$123.6M
Q1 24
$61.0M
$137.8M
Total Debt
CWBC
CWBC
DTIL
DTIL
Q4 25
$69.5M
Q3 25
Q2 25
Q1 25
Q4 24
$69.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CWBC
CWBC
DTIL
DTIL
Q4 25
$409.6M
$92.2M
Q3 25
$397.6M
$16.6M
Q2 25
$380.0M
$34.1M
Q1 25
$372.2M
$49.3M
Q4 24
$362.7M
$56.4M
Q3 24
$363.5M
$64.9M
Q2 24
$350.2M
$74.7M
Q1 24
$211.7M
$37.2M
Total Assets
CWBC
CWBC
DTIL
DTIL
Q4 25
$3.7B
$154.4M
Q3 25
$3.6B
$93.5M
Q2 25
$3.6B
$108.9M
Q1 25
$3.6B
$124.4M
Q4 24
$3.5B
$136.4M
Q3 24
$3.5B
$153.3M
Q2 24
$3.5B
$165.8M
Q1 24
$2.4B
$184.7M
Debt / Equity
CWBC
CWBC
DTIL
DTIL
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWBC
CWBC
DTIL
DTIL
Operating Cash FlowLast quarter
$46.1M
$-11.3M
Free Cash FlowOCF − Capex
$43.6M
$-11.3M
FCF MarginFCF / Revenue
113.9%
-32.9%
Capex IntensityCapex / Revenue
6.6%
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$77.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWBC
CWBC
DTIL
DTIL
Q4 25
$46.1M
$-11.3M
Q3 25
$13.2M
$-15.3M
Q2 25
$11.5M
$-20.3M
Q1 25
$11.1M
$-19.1M
Q4 24
$22.2M
$-58.4M
Q3 24
$7.8M
$-5.9M
Q2 24
$5.2M
$-14.9M
Q1 24
$4.0M
$-19.0M
Free Cash Flow
CWBC
CWBC
DTIL
DTIL
Q4 25
$43.6M
$-11.3M
Q3 25
$12.8M
Q2 25
$10.6M
$-20.3M
Q1 25
$10.8M
$-19.1M
Q4 24
$17.2M
$-58.7M
Q3 24
$5.2M
$-6.0M
Q2 24
$4.8M
$-14.9M
Q1 24
$3.6M
$-19.1M
FCF Margin
CWBC
CWBC
DTIL
DTIL
Q4 25
113.9%
-32.9%
Q3 25
33.7%
Q2 25
29.6%
-112627.8%
Q1 25
30.9%
-65917.2%
Q4 24
50.0%
-9199.8%
Q3 24
16.7%
-1033.2%
Q2 24
15.7%
-29.9%
Q1 24
17.3%
-108.4%
Capex Intensity
CWBC
CWBC
DTIL
DTIL
Q4 25
6.6%
0.1%
Q3 25
1.1%
0.0%
Q2 25
2.7%
11.1%
Q1 25
0.9%
220.7%
Q4 24
14.7%
39.2%
Q3 24
8.1%
6.8%
Q2 24
1.4%
0.1%
Q1 24
2.1%
0.5%
Cash Conversion
CWBC
CWBC
DTIL
DTIL
Q4 25
-0.56×
Q3 25
1.21×
Q2 25
1.47×
Q1 25
1.33×
Q4 24
Q3 24
2.29×
Q2 24
-0.45×
Q1 24
1.09×
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons